Mark A. Raffeld
Impact in
- Pathology and Forensic Medicine top 0.01%
- Lymphoma Diagnosis and Treatment
- Genetics top 0.05%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Lymphoma Diagnosis and Treatment 196
- Oncology 181
- Viral-associated cancers and disorders 111
- Co-authors
- Elaine S. Jaffe (174 shared papers)Stefania Pittaluga (117 shared papers)Lynn R. Sorbara (40 shared papers)Liqiang Xi (84 shared papers)ES Jaffe (18 shared papers)Steven A. Rosenberg (9 shared papers)Maryalice Stetler‐Stevenson (32 shared papers)Mark E. Dudley (4 shared papers)
- Journals
- Blood (88 papers)The American Journal of Surgical Pathology (44 papers)American Journal of Clinical Pathology (16 papers)Clinical Cancer Research (16 papers)Modern Pathology (15 papers)
- Partner nations
- United StatesGermanySpain
In The Last Decade
Mark A. Raffeld
421 papers receiving 29.0k citations
Mark A. Raffeld's Hit Papers
Peers
Comparison fields: 5 of 145
- Pathology and Forensic Medicine 11.2k
- Genetics 5.7k
- Oncology 14.1k
- Immunology 7.7k
- Dermatology 2.5k
Countries citing papers authored by Mark A. Raffeld
This map shows the geographic impact of Mark A. Raffeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Raffeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Raffeld more than expected).
Fields of papers citing papers by Mark A. Raffeld
This network shows the impact of papers produced by Mark A. Raffeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Raffeld. The network helps show where Mark A. Raffeld may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark A. Raffeld, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 428 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes Hit paper breakdown → | 2002 | 2311 |
| 2 | Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19 Hit paper breakdown → | 2010 | 1102 |
| 3 | Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma Hit paper breakdown → | 2006 | 657 |
| 4 | A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1–Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response Hit paper breakdown → | 2014 | 637 |
| 5 | B-cell Maturation Antigen Is a Promising Target for Adoptive T-cell Therapy of Multiple Myeloma Hit paper breakdown → | 2013 | 526 |
| 6 | 1994 | 492 | |
| 7 | 1992 | 444 | |
| 8 | EBV Positive Mucocutaneous Ulcer—A Study of 26 Cases Associated With Various Sources of Immunosuppression Hit paper breakdown → | 2010 | 436 |
| 9 | 1999 | 343 | |
| 10 | Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor–transduced T Cells Targeting EGFRvIII in Patients With Glioblastoma Hit paper breakdown → | 2019 | 321 |
| 11 | 2002 | 267 | |
| 12 | 2003 | 266 | |
| 13 | 1991 | 262 | |
| 14 | 2017 | 262 | |
| 15 | 2008 | 261 | |
| 16 | 2011 | 258 | |
| 17 | 1996 | 249 | |
| 18 | 2000 | 242 | |
| 19 | 1996 | 239 | |
| 20 | 2008 | 237 |
About Mark A. Raffeld
Mark A. Raffeld is a scholar working on Pathology and Forensic Medicine, Oncology, Genetics, Immunology and Dermatology, having authored 428 papers that have together received 30.2k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (196 papers), Viral-associated cancers and disorders (111 papers), Chronic Lymphocytic Leukemia Research (90 papers), Cutaneous lymphoproliferative disorders research (38 papers), Immune Cell Function and Interaction (36 papers), Eosinophilic Disorders and Syndromes (28 papers), T-cell and Retrovirus Studies (25 papers) and Histiocytic Disorders and Treatments (22 papers). The work is most often cited by research in Pathology and Forensic Medicine (11.2k citations), Genetics (5.7k citations), Oncology (14.1k citations), Immunology (7.7k citations) and Dermatology (2.5k citations). Mark A. Raffeld has collaborated with scholars based in United States, Germany and Spain. Frequent co-authors include Elaine S. Jaffe, Stefania Pittaluga, Lynn R. Sorbara, Liqiang Xi, ES Jaffe, Steven A. Rosenberg, Maryalice Stetler‐Stevenson, Mark E. Dudley, Wyndham Hopkins Wilson and Richard Mark Sherry. Their work appears in journals such as Blood, The American Journal of Surgical Pathology, American Journal of Clinical Pathology, Clinical Cancer Research and Modern Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.